Epperly Melissa B,

CIK 1807359 · Chief Financial Officer · last filed 2026-04-21

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.19M

Companies

5

Total Filings

49

Lifetime Open-Market Net

-$4.36M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ROIV Director 16,474 $30.04 $494.9K -$1.20M 16 2026-04-21
NAUT Director $2.24 $0 4 2025-06-25
ZNTL Chief Financial Officer 451,449 $3.75 $1.69M -$3.15M 23 2024-02-12
Roivant Sciences Ltd. (ROIVW) Delisted Director 1,280 $2.75 $3.5K $0 2 2023-07-06
Kinnate Biopharma Inc. (KNTE) Delisted Director $2.65 $0 3 2023-06-13

Recent Filings · Page 5 of 5

49 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-04-06 ZNTL Sell (S) −17,107 -$742.3K EDGAR
2021-03-03 ZNTL Sell (S) −3,083 -$128.5K EDGAR
2021-02-16 ZNTL Grant (A) +15,000 $0 EDGAR
2021-02-03 ZNTL Sell (S) −3,083 -$115.8K EDGAR
2021-01-06 ZNTL Sell (S) −3,083 -$160.0K EDGAR
2020-12-08 ZNTL Sell (S) −13,684 -$714.1K EDGAR
2020-12-03 ZNTL Sell (S) −3,083 -$158.7K EDGAR
2020-11-25 ZNTL Mixed +16,917 $216.4K EDGAR
2020-04-09 ZNTL Grant (A) +147,394 $0 EDGAR
Showing 4149 of 49
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.